Prof Dr. Prashant Kumar | lung cancer | Research Visionary Award

Karkinos Foundation & Karkinos HealthCare- India

Author Profile

• Scopus Profile
• Orcid Profile
• Google Scholar Profile

🎓Early Academic Pursuits

Prashant Kumar, Ph.D., embarked on his academic journey with a solid foundation in biotechnology. He earned his M.Sc. in Biotechnology from the University of Allahabad, India, in 2002. His quest for knowledge led him to the prestigious Max Planck Institute for Infection Biology in Berlin, Germany, where he pursued his Ph.D. in Molecular Biology. During his doctoral studies, Dr. Kumar was awarded the International Max-Planck Fellowship, allowing him to delve deeply into the molecular mechanisms of disease. His exceptional research earned him the Magna Cum Laude distinction for his Ph.D. thesis in 2009. This period was marked by rigorous academic training and significant research contributions, setting the stage for his future endeavors in cancer biology.

🏢Professional Endeavors

Dr. Kumar’s professional journey is marked by his roles as a researcher and academician. After completing his Ph.D., he moved to the University of Massachusetts Medical School in Worcester, USA, where he worked as a Postdoctoral Research Associate in the Department of Cancer Biology. Here, he established a novel mouse model of malignant breast cancers and contributed to the understanding of tumor suppressor mutations. In 2012, he joined the Institute of Molecular and Cell Biology (IMCB) A*STAR in Singapore as a Research Scientist ‘II’. His work took a translational turn, focusing on the development of point-of-care diagnostic platforms for cancer biomarkers. His career then took him to India, where he held prominent positions at the Institute of Bioinformatics in Bangalore and Somaiya Vidyavihar University in Mumbai. Currently, he serves as the Chief Scientific Officer at Karkinos HealthCare and the Research Director at Karkinos Foundation, Mumbai, while also being an Adjunct Professor at the Indian Institute of Technology (IIT) Kanpur.

🔬Contributions and Research Focus

Dr. Kumar’s research has significantly advanced the field of cancer biology. His early work at the Max Planck Institute and UMMS provided critical insights into breast cancer biology, specifically the role of the pRb family of proteins and their interaction with Brca1 and p53 in tumor progression. At IMCB, he shifted towards more practical applications, developing diagnostic tools for bladder cancer. His research interests encompass a wide range of cancer types, including cervical, breast, bladder, lung, and head and neck cancers. His specialization areas include liquid biopsy, circulating tumor cells (CTCs), cancer genomics, precision oncology, and proteomics. Dr. Kumar’s efforts have led to significant advancements in the early diagnosis and personalized treatment of cancer, particularly through his work on cancer neoantigens, cancer vaccines, and the application of bioinformatics in cancer research.

🏆Accolades and Recognition

Throughout his illustrious career, Dr. Kumar has received numerous accolades. He was honored with the Precision Researcher of the Year award at the Precision Medicine India Awards in 2024 by Voice of Healthcare. In 2021, he received the prestigious National Award for Academic Clinical Research from the Indian Society of Clinical Research (ISCR). His groundbreaking research has also earned him the Ramanujan Fellowship awarded by the Department of Science and Technology (DST), Government of India, in 2015. Dr. Kumar’s contributions to cancer research have been recognized globally, including an NIH-Fellowship for his postdoctoral research and the International Max-Planck Fellowship for his Ph.D. studies.

🌟Impact and Influence

Dr. Kumar’s work has had a profound impact on the field of cancer research and diagnostics. His development of diagnostic platforms and biomarker discovery has paved the way for improved cancer detection and treatment strategies. His research on the molecular pathways involved in cancer progression has provided valuable insights into the mechanisms of drug resistance and the identification of therapeutic targets. Dr. Kumar’s contributions have been instrumental in advancing precision oncology, enabling the development of personalized treatment plans for cancer patients based on their genetic profiles.

🌐Legacy and Future Contributions

As a leading figure in cancer research, Dr. Kumar continues to push the boundaries of scientific discovery. His current research focuses on profiling somatic and germline mutation landscapes in Indian cohorts, identifying mutational signatures in exceptional responders, and developing novel point-of-care diagnostic platforms. His work aims to uncover India-specific genetic signatures and improve the understanding of cancer biology in diverse populations. Dr. Kumar’s commitment to translational research ensures that his findings have a direct impact on clinical practice, ultimately improving patient outcomes.Dr. Prashant Kumar’s legacy is defined by his relentless pursuit of knowledge, groundbreaking research, and dedication to advancing cancer diagnostics and treatment. His contributions to the field have not only enhanced our understanding of cancer biology but also paved the way for innovative approaches in precision medicine. As he continues to lead cutting-edge research at Karkinos HealthCare and Karkinos Foundation, Dr. Kumar’s work promises to make significant strides in the fight against cancer, leaving a lasting impact on the scientific community and beyond.